Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,933,815
-
Share change
-
+4,298,267
-
Total reported value
-
$2,950,054,648
-
Put/Call ratio
-
44%
-
Price per share
-
$61.55
-
Number of holders
-
174
-
Value change
-
+$259,913,978
-
Number of buys
-
99
-
Number of sells
-
67
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q3 2018
As of 30 Sep 2018,
AERIE PHARMACEUTICALS INC - COM (AERI) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,933,815 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Partner Fund Management, L.P., Foresite Capital Management III, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Foresite Capital Management II, LLC, CITADEL ADVISORS LLC, and JENNISON ASSOCIATES LLC.
This page lists
174
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.